Proteinase MMP và các chất ức chế mô của Proteinase MMP

10.1074/jbc.274.31.21491

10.1146/annurev.cellbio.17.1.463

Woessner JF. The matrix metalloproteinase family. In: Parks WC Mecham RP eds. Matrix Metalloproteinases. San Diego Calif: Academic Press; 1998: 1–13.

Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997; 74: 111–122.

10.1016/S0167-4838(99)00279-4

10.1161/res.89.3.201

10.1161/res.90.3.251

10.1161/01.res.0000013290.12884.a3

10.1242/dev.127.4.907

10.1002/j.1460-2075.1990.tb07493.x

10.1074/jbc.274.49.34706

10.1042/bj3090299

10.1074/jbc.270.11.5872

10.1016/S0014-5793(01)02723-5

10.1074/jbc.272.36.22389

10.1038/90100

10.1021/bi00496a016

Uria JA, López-Otín C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res. 2000; 60: 4745–4751.

10.1074/jbc.M002349200

10.1074/jbc.272.4.2446

10.1016/S0092-8674(00)80064-1

10.1055/s-0037-1616232

10.1046/j.0953-816x.2001.01462.x

Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, López-Otín C. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res. 2000; 60: 877–882.

10.1038/sj.cr.7290028

10.1016/S0021-9258(20)80459-1

10.1073/pnas.93.9.3942

10.1074/jbc.272.7.4281

10.1016/S0165-2478(97)00057-6

10.1016/S0945-053X(00)00121-9

10.1074/jbc.273.28.17893

10.1074/jbc.274.8.4570

10.1074/jbc.M006493200

10.1016/S0378-1119(01)00360-2

10.1074/jbc.M001599200

10.1046/j.1523-1747.2002.01790.x

10.1002/pro.5560041002

10.1016/0014-5793(93)80312-I

10.1007/s000180050320

10.1126/science.284.5420.1667

10.1074/jbc.M101105200

10.1016/S0022-2836(02)00558-2

10.1074/jbc.272.47.29975

10.1074/jbc.M207446200

10.1073/pnas.102185399

10.1016/S0968-0004(99)01384-5

Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 1997; 378: 151–160.

10.1073/pnas.87.14.5578

10.1021/bi00090a003

10.1042/bj2540731

10.1021/bi00476a020

10.1126/science.1073634

10.1055/s-0037-1616230

10.1515/bchm.1998.379.2.185

10.1038/375244a0

Woessner JF Nagase H. Matrix Metalloproteinases and TIMPs. Oxford UK: Oxford University Press; 2000.

10.1111/j.1432-1033.1997.t01-1-00653.x

10.1074/jbc.270.39.23013

Llano E, Pendas AM, Freije JP, Nakano A, Knäuper V, Murphy G, López-Otín C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res. 1999; 59: 2570–2576.

10.1074/jbc.274.13.8925

10.1074/jbc.275.19.14046

10.1074/jbc.270.10.5331

10.1074/jbc.273.2.871

10.1074/jbc.M001270200

10.1093/emboj/20.17.4782

10.1042/bj3450511

10.1074/jbc.M108643200

10.1006/bbrc.2001.4323

10.1074/jbc.271.29.17124

10.1016/S0014-5793(02)03654-2

10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R

10.1074/jbc.272.18.12189

Nagase H. Substrate specificity of MMPs. In: Clendenninn NJ Appelt K eds. Matrix Metalloproteinase Inhibitors in Cancer Therapy. Totowa NJ: Humana Press Inc; 2001: 39–66.

10.1016/S0021-9258(17)37419-7

10.1074/jbc.271.8.4335

10.1074/jbc.M004039200

10.1385/MB:22:1:051

10.1074/jbc.272.35.22053

10.1083/jcb.137.6.1445

10.1172/JCI119001

10.1126/science.277.5323.225

10.1083/jcb.148.3.615

10.1083/jcb.153.5.893

10.1523/JNEUROSCI.22-23-10408.2002

10.1016/S0955-0674(00)00248-9

10.1021/bi00247a001

10.1042/bj2680267

10.1021/bi00205a010

10.1038/37995

10.1093/emboj/17.17.5238

10.1074/jbc.271.29.17119

10.1016/S0014-5793(98)01031-X

10.1016/S0014-5793(00)01528-3

10.1006/bbrc.2000.3835

10.1074/jbc.C000848200

10.1074/jbc.M000907200

10.1152/ajpheart.00684.2002

10.1242/jcs.00063

10.1038/sj.onc.1204097

10.1161/circ.100.5.533

10.1172/JCI2909

10.1016/S0076-6879(81)80056-0

10.1016/0014-5793(86)81074-2

10.1172/JCI10403

10.1074/jbc.275.2.1384

10.1038/362839a0

10.1016/S0092-8674(01)00597-9

10.1073/pnas.95.22.13221

10.1074/jbc.M205662200

10.1038/315768a0

10.1016/0014-5793(92)80386-U

10.1016/0014-5793(92)80015-9

10.1242/jcs.107.9.2373

10.1242/jcs.111.9.1147

10.1006/bbrc.1999.0408

10.1172/JCI4586

10.1002/jcp.1041570219

10.1074/jbc.M111507200

10.1038/sj.onc.1206292

10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B

10.1182/blood.V92.4.1342

10.1038/ng1294-352

10.1007/s003470050274

10.1016/S0021-9258(19)61475-4

Tabata Y, Isashiki Y, Kamimura K, Nakao K, Ohba N. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby’s fundus dystrophy with unusual clinical features. Hum Genet. 1998; 103: 179–182.

10.1074/jbc.M110870200

10.1016/S0945-053X(01)00180-9

10.1016/S0969-2126(01)00188-5

10.1002/elps.1150181505

10.1021/bi00036a018

10.1126/science.7531366

10.1083/jcb.125.3.681

10.1091/mbc.6.10.1287

10.1083/jcb.139.7.1861

10.1016/S0002-9440(10)65589-7

10.1038/ki.1997.191

10.1038/386616a0

10.1021/bi9731798

10.1074/jbc.272.46.28823

10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D

Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, Fukai N, Azar DT. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci. 2001; 42: 2517–2524.

10.1074/jbc.272.14.9237

Kadono Y, Okada Y, Namiki M, Seiki M, Sato H. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. Cancer Res. 1998; 58: 2240–2244.

10.1074/jbc.271.17.10079

10.1016/S0021-9258(18)47310-3

10.1210/endo.136.8.7543045

10.1074/jbc.272.41.25706

10.1074/jbc.M201674200

10.4049/jimmunol.161.7.3340

10.1038/sj.onc.1205684

10.1074/jbc.271.25.14657

10.1126/science.289.5482.1202

10.1182/blood.V100.4.1160.h81602001160_1160_1167

10.1042/bj3220809

10.1242/jcs.114.1.111

10.1074/jbc.M010135200

10.1016/S0960-9822(00)80113-X

Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001; 61: 237–242.